These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

848 related articles for article (PubMed ID: 33555429)

  • 1. Periphery and brain, innate and adaptive immunity in Parkinson's disease.
    Harms AS; Ferreira SA; Romero-Ramos M
    Acta Neuropathol; 2021 Apr; 141(4):527-545. PubMed ID: 33555429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of innate immunity and inflammation in Parkinson´s disease.
    Öberg M; Fabrik I; Fabrikova D; Zehetner N; Härtlova A
    Scand J Immunol; 2021 May; 93(5):e13022. PubMed ID: 33471378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innate and adaptive immune responses in Parkinson's disease.
    Schonhoff AM; Williams GP; Wallen ZD; Standaert DG; Harms AS
    Prog Brain Res; 2020; 252():169-216. PubMed ID: 32247364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neural and immune mechanisms in the pathogenesis of Parkinson's disease.
    Blandini F
    J Neuroimmune Pharmacol; 2013 Mar; 8(1):189-201. PubMed ID: 23378275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of innate and adaptive immunity in Parkinson's disease.
    Kannarkat GT; Boss JM; Tansey MG
    J Parkinsons Dis; 2013; 3(4):493-514. PubMed ID: 24275605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation and adaptive immunity in Parkinson's disease.
    Mosley RL; Hutter-Saunders JA; Stone DK; Gendelman HE
    Cold Spring Harb Perspect Med; 2012 Jan; 2(1):a009381. PubMed ID: 22315722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson's Disease.
    Caputi V; Giron MC
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29882798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroimmunological processes in Parkinson's disease and their relation to α-synuclein: microglia as the referee between neuronal processes and peripheral immunity.
    Sanchez-Guajardo V; Barnum CJ; Tansey MG; Romero-Ramos M
    ASN Neuro; 2013 Apr; 5(2):113-39. PubMed ID: 23506036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of α-synuclein in inducing innate and adaptive immunity in Parkinson disease.
    Allen Reish HE; Standaert DG
    J Parkinsons Dis; 2015; 5(1):1-19. PubMed ID: 25588354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune system responses in Parkinson's disease: Early and dynamic.
    Tansey MG; Romero-Ramos M
    Eur J Neurosci; 2019 Feb; 49(3):364-383. PubMed ID: 30474172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The systemic immune response in Parkinson's disease: focus on the peripheral immune component.
    Lauritsen J; Romero-Ramos M
    Trends Neurosci; 2023 Oct; 46(10):863-878. PubMed ID: 37598092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-Cell-Driven Inflammation as a Mediator of the Gut-Brain Axis Involved in Parkinson's Disease.
    Campos-Acuña J; Elgueta D; Pacheco R
    Front Immunol; 2019; 10():239. PubMed ID: 30828335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innate and adaptive immunity for the pathobiology of Parkinson's disease.
    Stone DK; Reynolds AD; Mosley RL; Gendelman HE
    Antioxid Redox Signal; 2009 Sep; 11(9):2151-66. PubMed ID: 19243239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral innate immune and bacterial signals relate to clinical heterogeneity in Parkinson's disease.
    Wijeyekoon RS; Kronenberg-Versteeg D; Scott KM; Hayat S; Kuan WL; Evans JR; Breen DP; Cummins G; Jones JL; Clatworthy MR; Floto RA; Barker RA; Williams-Gray CH
    Brain Behav Immun; 2020 Jul; 87():473-488. PubMed ID: 32006615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunology of West Nile Virus Infection and the Role of Alpha-Synuclein as a Viral Restriction Factor.
    Lesteberg KE; Beckham JD
    Viral Immunol; 2019; 32(1):38-47. PubMed ID: 30222521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immune system in Parkinson's disease: what we know so far.
    Roodveldt C; Bernardino L; Oztop-Cakmak O; Dragic M; Fladmark KE; Ertan S; Aktas B; Pita C; Ciglar L; Garraux G; Williams-Gray C; Pacheco R; Romero-Ramos M
    Brain; 2024 Oct; 147(10):3306-3324. PubMed ID: 38833182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson's disease.
    Williams GP; Schonhoff AM; Jurkuvenaite A; Thome AD; Standaert DG; Harms AS
    J Neuroinflammation; 2018 Aug; 15(1):244. PubMed ID: 30165873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Perspective on Roles Played by Innate and Adaptive Immunity in the Pathobiology of Neurodegenerative Disorders.
    Gendelman HE; Mosley RL
    J Neuroimmune Pharmacol; 2015 Dec; 10(4):645-50. PubMed ID: 26520433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated alpha-synuclein impairs innate immune cell function and provides a potential peripheral biomarker for Parkinson's disease.
    Gardai SJ; Mao W; Schüle B; Babcock M; Schoebel S; Lorenzana C; Alexander J; Kim S; Glick H; Hilton K; Fitzgerald JK; Buttini M; Chiou SS; McConlogue L; Anderson JP; Schenk DB; Bard F; Langston JW; Yednock T; Johnston JA
    PLoS One; 2013; 8(8):e71634. PubMed ID: 24058406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-Synuclein as a Prominent Actor in the Inflammatory Synaptopathy of Parkinson's Disease.
    Cardinale A; Calabrese V; de Iure A; Picconi B
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.